Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kits Eyecare Ltd T.KITS

Alternate Symbol(s):  KTYCF

Consumer Cyclical Specialty Retail
Kits Eyecare Ltd. is a Canada-based provider of vertically integrated and digitally native eyecare platforms. The Company operates through the sale of eyewear products to consumers. It offers customers access to a selection of contact lenses and eyeglasses, including its own KITS-designed products, as well as an advanced suite of online vision tools. Its collections include South Beach, Little... see more

TSX:KITS - Post Discussion

Kits Eyecare Ltd > Canaccord
View:
Post by retiredcf on Sep 27, 2024 8:35am

Canaccord

Canaccord Genuity’s Luke Hannan increased his target for Kits Eyecare Ltd.  to $14.50 from $12.50 with a “buy” rating. The average is $14.36.

Comment by retiredcf on Sep 27, 2024 9:49am
Here are their comments. GLTA “In our view, KITS remains well-positioned to maintain its current growth trajectory, driven by its state-of-the-art manufacturing operations, product innovation, and focus on high-return customer acquisition channels such as influencer marketing,” he said. “A deeper dive on each of the above topics throughout the day led us to come away with greater conviction that ...more  
Kits Eyecare Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities